Delivery Order SPE2DB22D2211-SPE2DB24FMGV2
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $3,664.43 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $5,889.65 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $53,727.38 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical products. The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for $2,309.43 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The $8,708.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $1,992.30, is for the supply of the drug Ozempic (1 mg/dose, 4 mg/3 ml, 3 ml) to support federal healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $15,486.20 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is not designated as a set-aside contract. The award has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $3,093.02 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $5,805.20, is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This order is not associated with a set-aside program. Amerisourcebergen Corporation, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,741.62 for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The contract has a firm fixed price pricing type and an ultimate completion date of May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMGV2Delivery Order
This federal contract award is for the delivery of the pharmaceutical product Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, valued at $1,554.57, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 5, 2023. This award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/4/23 |